| A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against Plasmodium falciparum Malaria JA Stoute, M Slaoui, DG Heppner, P Momin, KE Kester, P Desmons, ... New England Journal of Medicine 336 (2), 86-91, 1997 | 1085 | 1997 |
| Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites SL Hoffman, LML Goh, TC Luke, I Schneider, TP Le, DL Doolan, J Sacci, ... The Journal of infectious diseases 185 (8), 1155-1164, 2002 | 970 | 2002 |
| Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ... Nature medicine 9 (6), 729-735, 2003 | 711 | 2003 |
| Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of … KE Kester, JF Cummings, O Ofori-Anyinam, CF Ockenhouse, U Krzych, ... Journal of Infectious Diseases 200 (3), 337-346, 2009 | 581* | 2009 |
| A Recombinant Vesicular Stomatitis Virus Ebola Vaccine. JA Regules, B JH N Engl J Med 376 (4), 330-341, 2017 | 446 | 2017 |
| A field trial to assess a blood-stage malaria vaccine MA Thera, OK Doumbo, D Coulibaly, MB Laurens, A Ouattara, AK Kone, ... New England Journal of Medicine 365 (11), 1004-1013, 2011 | 424 | 2011 |
| Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit Vaccine DM Gordon, TW McGovern, U Krzych, JC Cohen, I Schneider, ... Journal of Infectious Diseases 171 (6), 1576-1585, 1995 | 402 | 1995 |
| Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya BR Ogutu, OJ Apollo, D McKinney, W Okoth, J Siangla, F Dubovsky, ... PloS one 4 (3), e4708, 2009 | 372 | 2009 |
| Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria KE Kester, DA McKinney, N Tornieporth, CF Ockenhouse, DG Heppner, ... The Journal of infectious diseases 183 (4), 640-647, 2001 | 356 | 2001 |
| Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway S Pichyangkul, K Yongvanitchit, U Kum-Arb, H Hemmi, S Akira, AM Krieg, ... The Journal of Immunology 172 (8), 4926-4933, 2004 | 347 | 2004 |
| Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-γ P Sun, R Schwenk, K White, JA Stoute, J Cohen, WR Ballou, G Voss, ... The Journal of Immunology 171 (12), 6961-6967, 2003 | 294 | 2003 |
| Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research DG Heppner Jr, KE Kester, CF Ockenhouse, N Tornieporth, O Ofori, ... Vaccine 23 (17-18), 2243-2250, 2005 | 256 | 2005 |
| Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine A Brockman, RN Price, M Van Vugt, DG Heppner, D Walsh, P Sookto, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (5 …, 2000 | 243 | 2000 |
| Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand F Nosten, C Luxemburger, DE Kyle, WR Ballou, J Wittes, EH Wah, ... The lancet 348 (9029), 701-707, 1996 | 238 | 1996 |
| Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A MD Spring, JF Cummings, CF Ockenhouse, S Dutta, R Reidler, E Angov, ... PloS one 4 (4), e5254, 2009 | 235 | 2009 |
| Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design KM VanBuskirk, MT O'Neill, P De La Vega, AG Maier, U Krzych, J Williams, ... Proceedings of the National Academy of Sciences 106 (31), 13004-13009, 2009 | 208 | 2009 |
| Update on the clinical development of candidate malaria vaccines WR Ballou, M Arevalo-Herrera, D Carucci, TL Richie, G Corradin, C Diggs, ... The Intolerable Burden of Malaria II: What's New, What's Needed: Supplement …, 2004 | 202 | 2004 |
| Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children C Simanjuntak, H Totosudirjo, N Witham, N Punjabi, D Burr, K Sorenson, ... The Lancet 340 (8821), 689-694, 1992 | 188 | 1992 |
| Salmonella typhi Vaccine Strain CVD 908 Expressing the Circumsporozoite Protein of Plasmodium falciparum: Strain Construction and Safety and Immunogenicity … C Gonzalez, D Hone, FR Noriega, CO Tacket, JR Davis, G Losonsky, ... Journal of Infectious Diseases 169 (4), 927-931, 1994 | 180 | 1994 |
| Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria CF Ockenhouse, W Hu, KE Kester, JF Cummings, A Stewart, DG Heppner, ... Infection and immunity 74 (10), 5561-5573, 2006 | 170 | 2006 |
Kent KesterIAVIVerified email at iavi.org
